"Anticoagulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that prevent BLOOD CLOTTING.
| Descriptor ID |
D000925
|
| MeSH Number(s) |
D27.505.954.502.119
|
| Concept/Terms |
Anticoagulants- Anticoagulants
- Anticoagulation Agents
- Agents, Anticoagulation
- Anticoagulant Agents
- Agents, Anticoagulant
- Anticoagulant Drugs
- Drugs, Anticoagulant
- Anticoagulant
|
Below are MeSH descriptors whose meaning is more general than "Anticoagulants".
Below are MeSH descriptors whose meaning is more specific than "Anticoagulants".
This graph shows the total number of publications written about "Anticoagulants" by people in this website by year, and whether "Anticoagulants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 2 | 1 | 3 |
| 1998 | 2 | 1 | 3 |
| 1999 | 5 | 2 | 7 |
| 2000 | 3 | 6 | 9 |
| 2001 | 1 | 2 | 3 |
| 2002 | 5 | 1 | 6 |
| 2003 | 4 | 4 | 8 |
| 2004 | 4 | 5 | 9 |
| 2005 | 5 | 4 | 9 |
| 2006 | 8 | 1 | 9 |
| 2007 | 4 | 3 | 7 |
| 2008 | 4 | 3 | 7 |
| 2009 | 9 | 6 | 15 |
| 2010 | 2 | 11 | 13 |
| 2011 | 4 | 7 | 11 |
| 2012 | 5 | 6 | 11 |
| 2013 | 6 | 8 | 14 |
| 2014 | 8 | 6 | 14 |
| 2015 | 7 | 7 | 14 |
| 2016 | 4 | 4 | 8 |
| 2017 | 6 | 2 | 8 |
| 2018 | 20 | 10 | 30 |
| 2019 | 5 | 6 | 11 |
| 2020 | 12 | 15 | 27 |
| 2021 | 10 | 20 | 30 |
| 2022 | 1 | 20 | 21 |
| 2023 | 1 | 10 | 11 |
| 2024 | 10 | 11 | 21 |
| 2025 | 11 | 8 | 19 |
| 2026 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anticoagulants" by people in Profiles.
-
Real-World Practice in Secondary Stroke Prevention Following Embolic Stroke of Undetermined Source: Secondary Analysis of the CASPR Registry. Neurol Clin Pract. 2026 Aug; 16(4):e200631.
-
Management of Patients at Risk of Ischemic Stroke With Left Ventricular Systolic Dysfunction in the Absence of Intracardiac Thrombus: A Scientific Statement From the American Heart Association. Stroke. 2026 Aug; 57(8):e437-e454.
-
Recurrent Stroke in Patients With Cryptogenic Stroke and Left Ventricular Injury: The Cardiac Abnormalities in Stroke Prevention and Recurrence (CASPR) Study. Stroke. 2026 May; 57(5):1175-1186.
-
Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trial. Eur Heart J. 2026 Feb 23; 47(8):942-952.
-
Effects of Continued Perioperative Anticoagulation on Cochlear Implant Outcomes. Otol Neurotol. 2026 Mar 01; 47(3):e539-e543.
-
Extended venous thromboembolism prophylaxis after bariatric surgery does not increase postoperative bleeding complications. Surgery. 2026 Mar; 191:109918.
-
Impact of serum versus anticoagulant-containing plasma on influenza virus neuraminidase-based serological assays. Vaccine. 2026 Jan 01; 69:127956.
-
Local ancestry-informed GWAS of warfarin dose requirement in African Americans identifies a CYP2C19 splicing QTL. Am J Hum Genet. 2025 11 06; 112(11):2708-2719.
-
Intracranial Occlusion in Cryptogenic Stroke Is Not Predictive of Recurrent Ischemic Stroke: A Propensity-Score Matched Analysis of the Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence Study. J Am Heart Assoc. 2025 10 07; 14(19):e041500.
-
Regional Citrate Anticoagulation and Infectious Complications in Critically Ill Children and Young Adults Receiving Continuous Renal Replacement Therapy. Nephron. 2026; 150(1):12-24.